We are Sorry, This Page doesn't Exist

GST impact: Pharma sector supply chain coping well after rollout

Time is needed to prepare for commercial launch of the new products: Biocon CMD Kiran Mazumdar Shaw.....»»

Category: topSource: business-standardJul 6th, 2017

Trai begins process for network testing before commercial launch of service

Telecom Regulatory Authority of India on Monday commenced the consultation process to frame rules for network testing before full-fledged commercial launch, a move ostensibly taken in the light of controversy that erupted at the .....»»

Category: topSource: business-standardMay 1st, 2017

After pact with Horizon, Hillsboro school aims to be training ground for commercial pilots

A Hillsboro flight school known as one of the biggest on the West Coast on Monday announced a partnership with Horizon Air to launch a program to develop pilots for the Seattle-based regional airline. Horizon, a division of Seattle-based Alaska Air Group.....»»

Category: topSource: bizjournalsDec 12th, 2016

Otonomy Inc (OTIC) Stock: Pivotal Data In Focus

Otonomy Inc (NASDAQ:OTIC) is set to put out data from a phase III in its lead asset, Otiprio, before the year draws to a close. The drug is already approved in one indication, and is performing pretty well as part of its initial commercial launch, and if .....»»

Category: topSource: insidermonkeyOct 13th, 2016

Wedbush Boosts Target On Sarepta Shares From $66 To $72 Amid US Launch Of Exondys 51

Commenting on the U.S. commercial launch of Sarepta Therapeutics Inc’s (NASDAQ: SRPT) Exondys 51, Wedbush’s Heather Behanna said that the initial adoption would likely be rapid although logistical challenges may continue. Latest Ratings for SRPT .....»»

Category: blogSource: benzingaOct 10th, 2016

Facebook Deepens Partnership With PayPal With Messenger Payments

Meanwhile, Apple Pay Cash's launch looms on the horizon......»»

Category: topSource: foxnewsOct 20th, 2017

Imprimis Pharma to take on Allergan"s Restasis with cheaper product

(Reuters) - Shares of Imprimis Pharmaceuticals Inc sky-rocketed as much as 91 percent on Thursday, after the company said it would launch a cheaper alternative to Allergan Plc's controversial dry eye drug, Restasis, by next month......»»

Category: topSource: reutersOct 20th, 2017

Bucks pharma firm completes $138M IPO

The company plans to use the bulk of the funds for the launch of its recently approved nasal polyps treatment......»»

Category: topSource: bizjournalsOct 18th, 2017

The first iPhone X units have shipped, but most users will have to wait

Some lucky buyers will get their iPhone X on November 3rd when the handset is set to launch in initial markets, but most Apple fans will have to wait weeks or even months to have one shipped to their door. .....»»

Category: topSource: moneycentralOct 16th, 2017

Your Daily Pharma Scoop: ACRX Second Chance, AERI Rhopressa Success, Aratana ENTYCE Launch

Your Daily Pharma Scoop: ACRX Second Chance, AERI Rhopressa Success, Aratana ENTYCE Launch.....»»

Category: topSource: seekingalphaOct 16th, 2017

Muscle Maker Grill plans $20M IPO

Muscle Maker Inc., the owner of health-focused chain Muscle Maker Grill, plans to launch a Regulation A+ initial public offering to raise up to nearly $20 million.  The company plans to offer about 3.33 million shares of common stock at $6 per sh.....»»

Category: topSource: bizjournalsOct 16th, 2017

Andreas Halvorsen Dives into Deciphera Pharma

Company launches initial publ.....»»

Category: smallbizSource: nytOct 12th, 2017

Swiggy partners Indifi to launch Capital Assist programme for restaurants

Swiggy Capital Assist will enable partner restaurants to avail collateral-free loans without initial deposits at a fair interest rate.....»»

Category: topSource: business-standardOct 12th, 2017

CarGurus, Hair Transplant Firm Among This Week"s IPOs

If you’ve rapaciously bought stock in the proliferating pharma space, you’ve had a good year in initial public offerings. But this isn’t your week. read more.....»»

Category: blogSource: benzingaOct 11th, 2017

Seattle Genetics Begins Phase II Study of Cancer Candidate

Seattle Genetics (SGEN) and Astellas Pharma initiate phase II study-EV-201 of enfortumab vedotin for patients with locally advanced or metastatic urothelial cancer. .....»»

Category: personnelSource: nytOct 11th, 2017

Overstock"s Regulated Token Exchange Will Launch with Own ICO

Retail giant is to launch its new regulated token exchange with its own initial coin offering (ICO), according to a news report......»»

Category: forexSource: coindeskOct 10th, 2017

Blue Apron Competitor HelloFresh to Launch IPO

HelloFresh SE will launch an initial public offering on the regulated market of the Frankfurt Stock Exchange, as more companies look to compete in the fast-growing meal-kit industry that caters to time-strapped home cooks......»»

Category: smallbizSource: wsjOct 10th, 2017

SpaceX Has Successful Launch As It Ramps Up Operational Tempo

Space Exploration Technologies blasted 10 commercial satellites into orbit, completing the first of a pair of consecutive launches slated from opposite coasts in roughly two days......»»

Category: smallbizSource: wsjOct 9th, 2017

Horizon Pharma Breaks Above 200-Day Moving Average - Bullish for HZNP

Market News Video.....»»

Category: topSource: redinewsOct 5th, 2017

Synergy Pharmaceuticals" First Commercial Launch Trajectory Solidifies

Synergy Pharmaceuticals" First Commercial Launch Trajectory Solidifies.....»»

Category: topSource: seekingalphaOct 3rd, 2017